Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_02114
Species: Homo sapiens
Position : chrX:49268807-49270673
Year: 2026
Title: FOXP3 expression depends on cell-type-specific cis-regulatory elements and transcription factor circuitry.
Genome Build: hg38
Enhancer Type: Silencer
Condition: Normal
PMID:  41237776
Tissue: blood
Tissue Ontology ID: UBERON:0000178
Cell Source: Primary conventional CD4+ T cells
Cell Type: CD4-positive, alpha-beta T cell
Cell Ontology ID: CL:0000624
Experiment Type: Silencer activity assay; Functional perturbation assay; TF binding assay
High Throughput Method: Pooled CRISPRi locus-tiling screen; pooled CRISPRn TF screen; ATAC-seq; H3K27ac ChIP-seq; EGR2 ChIP-seq; RNA-seq
Low Throughput Method: Paired-Cas9 RNP tiled deletion; CRISPRoff targeted epigenetic silencing; EGR2 knockout; FOXP3 flow cytometry; targeted bisulfite sequencing; targeted amplicon sequencing
About Target Gene
Target gene : FOXP3
About TF
TF name : EGR2
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
EGR2 Activation of anterior HOX genes in hindbrain development during early embryogenesis reactome 120
EGR2 Calcineurin-regulated NFAT-dependent transcription in lymphocytes pid 50
EGR2 IL4-mediated signaling events pid 66
EGR2 Transcriptional regulation of white adipocyte differentiation reactome 79
EGR2 Validated transcriptional targets of TAp63 isoforms pid 54
EGR2 Hs_Fatty_Acid_Beta_Oxidation_WP143_79783 wikipathways 14
Enhancer Associated Network
Overlapping Enhancers (hg38) 1 found
Enhancer ID Position Tissue Cell Disease
E_02126 chrX:49268807-49270673 NA NA NA
Expression of Target Genes for the Enhancer